Sun Pharmaceutical Industries Limited (SUNPHARMA)
ISIN: CNE100005139 Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
829.4
0.15(0.02%)

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances, as well as over-the-counter products. Sun Pharmaceutical Industries Limited was founded in 1983 and is based in Mumbai, India.

Pricing Updates

TODAY'S HIGH

839.65

TODAY'S LOW

821.9

52 WEEK HIGH

967.05

52 WEEK LOW

664.2

Major Holders

% of Shares Held by
All Insider

16.56%

% of Shares Held by
Institutions

25.53%

% of Float Held by
Institutions

30.60%

Number of Institutions
Holding Shares

219

Company Overview

MARKET CAP

199000.44 Cr.

ETERPRISE VALUE

190457.85 Cr.

NO. OF SHARES

239.93 Cr.

BOOK VALUE

200.288

DIV. YIELD

7%

DEBT

1290.30 Cr.

GROSS PROFIT

28302.95 Cr.

CASH

12667.28 Cr.

REVENUE

38654.48 Cr.

REVENUE/SHARE

160.631

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-3791.07 Cr.1373.27 Cr.-1701.92 Cr.1752.44 Cr.
Change To Liabilities369.92 Cr.381.46 Cr.-210.11 Cr.-854.46 Cr.
Total cashflows from Investing Activities-5724.74 Cr.536.22 Cr.-2588.84 Cr.-681.25 Cr.
Net Borrowings-2765.36 Cr.-4489.64 Cr.-3122.99 Cr.-237.20 Cr.
Total Cash from Financing Activities-5193.46 Cr.-5980.48 Cr.-5715.14 Cr.-2730.52 Cr.
Other Liabilities2224.44 Cr.3169.19 Cr.1225.94 Cr.-274.70 Cr.
Total Assets00038 Lakhs
Net Income3272.73 Cr.2903.82 Cr.3764.93 Cr.2665.42 Cr.
Change in Cash-1764.78 Cr.596.42 Cr.-1385.69 Cr.-844.15 Cr.
Effect of Exchange Rate127.43 Cr.-129.69 Cr.363.52 Cr.325.65 Cr.
Total Cash from Operating Activities8984.54 Cr.6170.37 Cr.6554.77 Cr.2196.45 Cr.
Depreciation2143.74 Cr.2029.56 Cr.2008.48 Cr.1722.93 Cr.
Other Cashflows from Investing Activities210.13 Cr.209.36 Cr.394.64 Cr.706.72 Cr.
Dividends Paid-2158.92 Cr.-1559.47 Cr.-1379.19 Cr.-480.18 Cr.
Change to Inventory306.95 Cr.-1080.29 Cr.256.77 Cr.-709 Cr.
Change to Account Receivables-1342.26 Cr.93.73 Cr.-374.05 Cr.-857.84 Cr.
Other Cashflows from Financing Activities-83.48 Cr.124.58 Cr.-1000.48 Cr.-1404.70 Cr.
Change to Net Income2009.02 Cr.-1377.49 Cr.-161.49 Cr.473.78 Cr.
Capital Expenditures-1495.04 Cr.-1170.13 Cr.-1542 Cr.-3212.82 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax4464.78 Cr.2787.04 Cr.4994.76 Cr.3808.74 Cr.
Minority Interest3054.89 Cr.3017.05 Cr.3860.24 Cr.3313.54 Cr.
Net Income8100.02 Cr.6427.62 Cr.4947.77 Cr.4737.31 Cr.
Selling General Administrative7300.83 Cr.6904.21 Cr.6398.59 Cr.6102.74 Cr.
Gross Profit28302.95 Cr.24279.62 Cr.23157.87 Cr.20682.02 Cr.
Ebit8100.02 Cr.6427.62 Cr.4947.77 Cr.4737.31 Cr.
Operating Income8100.02 Cr.6427.62 Cr.4947.77 Cr.4737.31 Cr.
Other Operating Expenses10758.36 Cr.8867.84 Cr.9758.73 Cr.8091.61 Cr.
Interest Expense-127.35 Cr.-141.43 Cr.-302.73 Cr.-550.58 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense1075.50 Cr.514.69 Cr.822.80 Cr.600.88 Cr.
Total Revenue38654.49 Cr.33498.14 Cr.32837.50 Cr.29065.91 Cr.
Total Operating Expenses30554.47 Cr.27070.52 Cr.27889.73 Cr.24328.60 Cr.
Cost of Revenue10351.54 Cr.9218.52 Cr.9679.63 Cr.8383.89 Cr.
Total Other Income Expense Net-3635.24 Cr.-3640.58 Cr.46.99 Cr.-928.57 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.3389.28 Cr.2272.35 Cr.4171.96 Cr.3207.86 Cr.
Net Income Applicable to Common Shares3272.73 Cr.2903.82 Cr.3764.93 Cr.2665.42 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets6028.20 Cr.5660.66 Cr.6359.45 Cr.6353.71 Cr.
Capital Surplus01187.41 Cr.1187.41 Cr.1193.29 Cr.
Total Liabilities18733.76 Cr.18186.90 Cr.19127.77 Cr.19971.21 Cr.
Stock Holder Equity48011.22 Cr.46462.78 Cr.45264.45 Cr.41409.06 Cr.
Minority Interest3054.89 Cr.3017.05 Cr.3860.24 Cr.3313.54 Cr.
Other Liabilities11912.62 Cr.8004.33 Cr.4813.18 Cr.3733.86 Cr.
Total Assets69799.87 Cr.67666.73 Cr.68252.46 Cr.64693.81 Cr.
Common Stock239.93 Cr.239.93 Cr.239.93 Cr.239.93 Cr.
Retained Earnings040188.74 Cr.38905.20 Cr.36913.04 Cr.
Other Liabilities1051.50 Cr.1143.14 Cr.1392.42 Cr.1108.98 Cr.
Good Will6549.45 Cr.6287.64 Cr.6481.46 Cr.5955.77 Cr.
Treasury Stock47771.29 Cr.4846.70 Cr.4931.91 Cr.3062.80 Cr.
Other Assets5823.70 Cr.7622.45 Cr.7285.30 Cr.6425.12 Cr.
Cash5033.35 Cr.6273.03 Cr.5676.61 Cr.7062.30 Cr.
Current Liabilities17200.55 Cr.16145.63 Cr.15706.43 Cr.17339.62 Cr.
Long Term Asset Charges2896.72 Cr.3556.44 Cr.3175.29 Cr.2554.87 Cr.
Short Long Term Debt0423.88 Cr.643.86 Cr.586.09 Cr.
Other Stockholder Equity47771.29 Cr.4846.70 Cr.4931.91 Cr.3062.80 Cr.
Property Plant Equipment11168.89 Cr.11171.51 Cr.11226.34 Cr.10938.21 Cr.
Total Cur. Assets35014.98 Cr.30442.08 Cr.31654.16 Cr.31069.19 Cr.
Long Term Investments5214.65 Cr.6482.39 Cr.5245.75 Cr.3951.81 Cr.
Net Tangible Assets35433.57 Cr.34514.48 Cr.32423.54 Cr.29099.58 Cr.
Short Term Investments7633.94 Cr.3259.15 Cr.4859.51 Cr.3558.29 Cr.
Net Receivables10762.86 Cr.9890.52 Cr.10510.58 Cr.10062.99 Cr.
Long Term Debt229.92 Cr.654.71 Cr.1777.61 Cr.1422.87 Cr.
Inventory8996.81 Cr.9361.80 Cr.8269.22 Cr.8262.40 Cr.
Accounts Payable4479.34 Cr.3973.66 Cr.3583.64 Cr.4147.87 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account